Meet Dr. Roxie

Fractional Chief Growth Officer | Board Director | Bestselling Author | Host of The Health Innovators Show

About Dr. Roxie

Dr. Roxie Mooney, DBA, is a nationally recognized healthcare growth strategist, board director, and Fractional Chief Growth Officer who helps PE-backed and mid-market healthtech and pharmacy companies scale and exit smarter, faster, and with greater enterprise value.

As CEO of Legacy DNA, she leads a human-first, AI-powered growth firm purpose-built for healthcare innovators and private equity operators. Her team applies proprietary commercialization and value creation frameworks that deliver speed, clarity, and measurable impact by accelerating traction, adoption, and valuation.

Dr. Roxie has been part of four successful exits, including helping grow BioPlus Specialty Pharmacy from $750M to $2B, leading to acquisitions by Nautic Partners and Elevance Health. Her experience spans digital health, specialty pharmacy, infusion, and broader healthcare innovation.

Expertise & Contributions

• Creator of the Exit Readiness Sprint™, Growth Gap Calculator™, and Early Adoption Framework™ and other proven systems that guide companies from growth plateaus to premium exits.

• Speaker & Educator at leading industry events including HLTH, HIMSS, ATA, HITLab, and Plug & Play Health.

• Bestselling Author of How Health Innovators Maximize Market Success, now used by thousands of healthcare leaders to commercialize more effectively.

• Host of The Health Innovators Show, where she interviews top founders, investors, and executives driving healthcare transformation.

• Former Professor & Mentor in Marketing and Leadership at Palm Beach Atlantic University and Rollins College.

• Board Member of Pneuma Systems Corporation, a company revolutionizing infusion therapy.

Education & Credentials

Dr. Roxie holds a Doctorate in Business Administration (Marketing Specialization) from Walden University, a Master’s in Organizational Leadership from Palm Beach Atlantic University, and a Bachelor’s in Organizational Communications from Rollins College. She also completed postgraduate studies in Disruptive Strategy under Clayton Christensen at Harvard Business School.